OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2025
(3)
2023
(1)
2021
(1)
2019
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study.
Not available
S-EPMC7907837
|
biostudies-literature
Cite
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II).
Not available
S-EPMC12058817
|
biostudies-literature
Cite
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
Not available
S-EPMC6440108
|
biostudies-literature
Cite
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).
Not available
S-EPMC12492580
|
biostudies-literature
Cite
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from
CaRe
, a multicentric, observational study.
Not available
S-EPMC10227592
|
biostudies-literature
Cite
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.
Not available
S-EPMC12152862
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets